2018•AME Medical JournalOpen access

Does non-malignant portal vein thrombosis affect outcomes of transjugular intrahepatic portosystemic shunt in patients with cirrhosis?

Sheena Pimpalwar, Nipun Kakkar, Wei Zhang

Abstract

Portal vein thrombosis (PVT) is no longer considered a contraindication for transjugular intrahepatic portosystemic shunt (TIPS). On the other hand, TIPS has shown to improve PVT (1) and reduce the risk of rebleeding as compared with endoscopic band ligation and propranolol albeit without providing a survival benefit (2,3). Also portal vein recanalization and TIPS in cirrhotics with chronic, obliterative PVT has increased the eligibility for liver transplantation and reduced the need for complex surgical grafts during transplantation (4,5).

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Transjugular intrahepatic portosystemic shunt, Contraindication, Portal vein thrombosis, Cirrhosis, Liver transplantation, Portal hypertension, Thrombosis